Immuno-radiothérapie : une revue du rationnel, développements cliniques récents et perspectives futures
Authors:
- 24 August 2022
- journal article
- research article
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 26 (6-7) , 955-961
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete RemissionsClinical Cancer Research, 2015
- Pembrolizumab for the Treatment of Non–Small-Cell Lung CancerNew England Journal of Medicine, 2015
- Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 BlockadeCancer Research, 2014
- Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapyOncoImmunology, 2014
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in miceJournal of Clinical Investigation, 2014
- Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell ImmunotherapyCancer Cell, 2013
- The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive ImmunityCancer Research, 2011
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure PathwayClinical Cancer Research, 2010
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 AntibodyClinical Cancer Research, 2009
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyJournal of Experimental Medicine, 2006